# A Study to Test the Non-Inferiority of Ferric Bepectate IV Against Ferric Carboxymaltose in Patients With Iron Deficiency Anemia

> **NCT07687784** · PHASE3 · NOT_YET_RECRUITING · sponsor: **AFT Pharmaceuticals, Ltd.** · enrollment: 1366 (estimated)

## Conditions studied

- Iron Deficiency Anemia (IDA)

## Interventions

- **DRUG:** Ferric Bepectate IV Injection
- **DRUG:** Ferric Carboxymaltose Injection [Ferinject]
- **DRUG:** Ferric Carboxymaltose Injection [Injectafer®]

## Key facts

- **NCT ID:** NCT07687784
- **Lead sponsor:** AFT Pharmaceuticals, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12
- **Primary completion:** 2028-06
- **Final completion:** 2028-07
- **Target enrollment:** 1366 (ESTIMATED)
- **Last updated:** 2026-08-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07687784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07687784, "A Study to Test the Non-Inferiority of Ferric Bepectate IV Against Ferric Carboxymaltose in Patients With Iron Deficiency Anemia". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07687784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*